ODOBGYNDECODED
Emergency Hub / Metabolic

⚡ Severe Hypo/Hyperglycaemia in Pregnancy

IN REVIEWPENDING CLINICAL VERIFICATIONTIME-CRITICAL PROTOCOLFull clinical topic →
1 RECOGNIZE
  • Hypoglycaemia: glucose <4 mmol/L (72 mg/dL); severity is determined by impaired consciousness/need for assistance, not only a <54 mg/dL threshold.
  • DKA: ketonaemia/acidosis in a patient with diabetes or hyperglycaemia; pregnancy DKA can occur with only modest or normal-range glucose. Measure ketones and VBG when unwell, vomiting or breathless.
2 CALL FOR HELP
  • Urgent obstetric and diabetes/medical review; DKA, impaired consciousness or haemodynamic compromise requires HDU/ICU capability.
3 IMMEDIATE ACTION
  1. HYPO, awake and safe swallowing: give 15–20 g rapid carbohydrate and recheck after 10–15 min; repeat if still low. If unconscious/unsafe swallowing, give IV glucose or IM glucagon using the exact cards below; never give oral fluids.
  2. DKA: begin monitored isotonic fluid replacement, insulin and electrolyte management with the medical/obstetric team. The usual adult first 1 L over 1 h requires adaptation in pregnancy, cardiac/renal disease or shock; reassess perfusion and fluid tolerance rather than simply prescribing “first litre fast”.
  3. Use SOLUBLE insulin at the stated concentration/rate, not NPH or a pen formulation IV. Measure potassium before and repeatedly during insulin; add glucose early for euglycaemic DKA or when glucose <14 mmol/L.
  4. Continue prescribed basal insulin unless the specialist team changes it. Identify infection, missed insulin, vomiting, steroid exposure or pump failure.

Drug doses & preparation

Choose the regimen for the stated indication. Alternatives are not instructions to give every medicine. Check prior doses, contraindications, concentration and the response before repeating.

Glucose — severe hypoglycaemiaJBDS-IP / ABCD / Diabetes UKchecked
Dose20 g glucose: 200 mL of 10% OR 100 mL of 20% solution
RouteIV infusion
FrequencyGive over 10–15 min; recheck glucose at 10 min and repeat if still <4 mmol/L with reassessment
DurationAcute rescue followed by longer-acting carbohydrate when awake and safe to swallow, or prescribed ongoing infusion
Preparation10% =100 mg/mL; 200 mL =20 g. 20% =200 mg/mL; 100 mL =20 g. Check IV patency and use a limited volume so a whole large bag cannot infuse accidentally
Max doseReassess after each 20 g treatment; recurrent/prolonged hypoglycaemia needs monitored ongoing treatment
  • Indication: Impaired consciousness or unsafe swallowing; never give oral fluid to an unconscious patient
Monitoring
  • Glucose 10 min after treatment, then serially until stable; consciousness, swallow and IV site
  • Identify missed food, insulin excess, renal failure or infection; do not omit basal insulin in type 1 diabetes
Contraindications: Do not give oral sugar when swallowing is unsafe; hypertonic glucose extravasation can injure tissue
Dose1 mg
RouteIM
FrequencyOne rescue dose; obtain IV access and recheck glucose after 10 min
DurationBridge to reliable glucose delivery; give carbohydrate after recovery
PreparationReconstitute the 1 mg vial with its supplied solvent immediately before IM use; verify final dose
Max dose1 mg initially; repeated glucagon may be ineffective and must not delay IV glucose
  • Indication: Severe insulin-associated hypoglycaemia when IV access is unavailable
Monitoring
  • Consciousness, glucose and nausea/vomiting; replenish carbohydrate once swallowing is safe
Contraindications: Reduced effectiveness with prolonged starvation, liver disease, depleted glycogen or repeated episodes
Soluble human insulin — DKAJBDS-IP / Diabetes UKchecked
Dose0.1 units/kg/hour IV; no routine IV insulin bolus. Consider 0.05 units/kg/hour once glucose <14 mmol/L alongside glucose infusion
RouteIV infusion pump
FrequencyContinuous with hourly response-based review
DurationContinue until ketones <0.6 mmol/L AND venous pH >7.3, clinical recovery and safe transition; not merely until glucose normalises
PreparationUsing U-100 SOLUBLE insulin: 50 units =0.5 mL; add to 49.5 mL sodium chloride 0.9% for FINAL 50 mL =1 unit/mL. At 0.1 units/kg/h, 70 kg =7 units/h =7 mL/h. NEVER use cloudy NPH IV
Max doseNo universal fixed hourly ceiling; inadequate ketone fall needs line/pump and dose reassessment. Potassium <3.5 mmol/L requires urgent senior-led replacement and insulin review
  • Indication: Pregnancy DKA, including euglycaemic DKA; urgent monitored obstetric/diabetes care
Monitoring
  • Hourly glucose and blood ketones; frequent VBG, potassium and electrolytes; target ketone fall ≥0.5 mmol/L/h
  • Add 10% glucose at 125 mL/h when glucose <14 mmol/L; euglycaemic pregnancy DKA may require glucose from the start
  • Continue usual long-acting basal insulin unless specialist contraindication; overlap IV insulin for 30–60 min after the appropriate subcutaneous meal dose during transition
Contraindications: Severe hypokalaemia, shock, renal/cardiac disease require immediate specialist adaptation; never prescribe insulin without a fluid/potassium plan
4 INVESTIGATIONS (never delaying treatment)
  • Hourly glucose and blood ketones; VBG/pH/bicarbonate, potassium/electrolytes, renal function and ECG; initial repeat electrolytes at least at 1 and 2 h, then according to clinical course.
  • Cultures/other precipitant tests when indicated; monitor fluid balance and fetal condition at a gestation where monitoring informs care.
5 DEFINITIVE MANAGEMENT
JBDS potassium decisions during DKA — use a monitored prescription
PotassiumAction
>5.5 mmol/L
No potassium in the initial replacement fluid; recheck as treatment rapidly lowers potassium.
3.5–5.5 mmol/L
If passing urine and renal status permits, usual replacement is premixed potassium 40 mmol/L in resuscitation fluid; account for the infusion rate and repeat levels.
<3.5 mmol/L
Urgent senior/critical-care review for additional replacement and an insulin plan. Do not continue an unreviewed insulin prescription; concentrated potassium requires the appropriate monitored setting.
Any potassium infusion
Never IV push potassium; use premixed/approved dilution and a labelled pump under the hospital policy.
  1. Continue IV insulin until ketones <0.6 mmol/L AND venous pH >7.3 with clinical recovery; glucose correction alone does not mean DKA has resolved.
  2. When eating and transitioning safely, give the appropriate subcutaneous insulin and overlap IV insulin for 30–60 min. Confirm the basal regimen and prevent another missed-insulin interval.
  3. Abnormal fetal monitoring may improve with maternal correction; do not make automatic delivery the treatment for DKA without an obstetric indication.
6 ESCALATION
  • Shock, severe acidosis, altered consciousness, hypokalaemia, respiratory compromise or failure of ketones to fall: critical-care/diabetes reassessment immediately.
7 POST-EVENT CARE
  • Review the precipitant and prescribe an explicit insulin plan, ketone/sick-day instructions and hypoglycaemia rescue plan.
  • Arrange diabetes and obstetric follow-up; verify access to insulin, meters/strips/CGM and ability to use them.

Admission & discharge after the acute event

Care setting: Outpatient coordinated care when stable; hospital admission for DKA or severe hypoglycaemia

Admission/discharge guidance checked 2026-10-18 against the linked sources. This is a clinical checklist for an individual decision, not an automatic discharge order.

When admission or continued hospital care is needed

  • Suspected DKA in pregnancy requires urgent hospital/critical-care assessment even when glucose is not extremely high. Admit severe/recurrent hypoglycaemia, inability to maintain intake or maternal/fetal compromise.

When clinic, day care or home care may be suitable

  • Stable type 1/type 2 diabetes needs joint obstetric/diabetes follow-up, not routine inpatient care.

Before going home

  • DKA resolution includes blood ketones <0.6 mmol/L and venous pH >7.3, clinical recovery and a safe insulin transition; normal glucose alone does not establish resolution.
  • Eating/drinking and glucose/electrolytes are stable; subcutaneous insulin has been given with the required overlap and specialist review. After hypoglycaemia, the cause/recurrence risk has been addressed.

Discharge medicines and treatment changes

  • Never stop all insulin in type 1 diabetes. After birth reduce insulin through an individual written plan with frequent glucose review; the GDM stopping rule does not apply.
  • Provide insulin, delivery devices, glucose/ketone strips and prescribed rescue treatment; teach the patient/family what to do when unwell.
Medicine doses — use only when indicated

Use the medicines selected for this patient. Listed alternatives are not instructions to prescribe all of them together. Confirm the actual remaining course, pregnancy/postnatal context and monitoring plan.

Rescue treatment when specifically prescribed with patient/family training.

Dose1 mg
RouteIM
FrequencyOne rescue dose; obtain IV access and recheck glucose after 10 min
DurationBridge to reliable glucose delivery; give carbohydrate after recovery
PreparationReconstitute the 1 mg vial with its supplied solvent immediately before IM use; verify final dose
Max dose1 mg initially; repeated glucagon may be ineffective and must not delay IV glucose
  • Indication: Severe insulin-associated hypoglycaemia when IV access is unavailable
Monitoring
  • Consciousness, glucose and nausea/vomiting; replenish carbohydrate once swallowing is safe
Contraindications: Reduced effectiveness with prolonged starvation, liver disease, depleted glycogen or repeated episodes

Tests, pending results and their reviewer

  • Review renal/electrolyte results after an acute event and record retinal/renal follow-up; glucose logs/CGM do not replace clinical review of recurrent lows.

Home care and counselling

  • Give sick-day and hypoglycaemia instructions, out-of-hours contacts, feeding-related hypo precautions and the exact pre-birth/post-birth insulin plan.

Follow-up: when and what to review

WhenAction / responsible service
Before discharge after DKA/severe hypoglycaemia
Diabetes-team review, education and a booked early contact; document the precipitating cause and prevention plan.
Within the existing joint pregnancy follow-up schedule / immediately after birth
Review glucose and doses promptly after treatment or physiological changes; do not wait for a routine 6-week check to adjust insulin.

Return urgently

  • Vomiting, ketones, dyspnoea, confusion, inability to maintain intake or severe/recurrent low glucose requires urgent hospital care.

Open the complete discharge checklist →

Sources